RadNet, Inc.
RDNT
Positions held
Your positionsRDNT isn't in your positions.
Add it to see shares, cost, and P&L here.
Bull / bear case
Site-generated summary from fundamentals, news, and score — not investment advice. As of 2026-10-08.
- RadNet is positioned well within the healthcare diagnostics industry, leveraging its strong revenue growth of 25% year-over-year to capture market share.
- In the latest quarter, RadNet reported a revenue increase of 8% compared to the prior quarter, reaching $623 million.
- The company's gross margin improved significantly to 14.1%, up from 4.4% in the previous quarter.
- Despite growth, RadNet faces challenges with a negative earnings growth rate of -49.1%, indicating potential profitability issues.
- The operating margin remains low at 6.8%, which could hinder future profitability and investment appeal.
- RadNet's net income was negative in the last quarter, reporting a loss of $33.466 million.
Fundamentals
| Market cap | $5.37B | Enterprise value | $7.12B | Trailing P/E | — | Forward P/E | 76.93 |
| PEG | 0.96 | Price / book | 4.89 | Beta | 1.41 | Dividend yield | 0.00% |
| Revenue growth | 25.0% | Earnings growth | -49.1% | Gross margin | 17.3% | Operating margin | 7.9% |
| Profit margin | -0.9% | ROE | 1.5% | ROA | 1.7% | Debt / equity | 1.57 |
| Current ratio | 1.48 | Free cash flow | $157.74M | Analyst recommendation | none | Mean target | $94.63 |
| 52w high | $85.84 | 52w low | $50.82 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $623M | $576M | $548M | $523M | $498M | — |
| Op margin | 6.8% | -3.4% | 6.4% | 6.3% | 6.7% | — |
| Net income | $7.5M | -$33.5M | -$0.6M | $5.4M | $14.5M | — |
| Gross margin | 14.1% | 4.4% | 13.9% | 13.9% | 13.9% | — |
| Gross profit | $88.1M | $25.1M | $75.9M | $72.5M | $69.1M | — |
| Operating income | $42.6M | -$19.8M | $35.1M | $32.7M | $33.2M | — |
- Revenue +8% vs prior quarter ($623M vs $576M).
- Gross margin 14.1% (was 4.4% prior quarter).
- Operating margin expanded to 6.8%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $2.0B | $1.8B | $1.6B | $1.4B | — |
| Op margin | 4.1% | 6.1% | 5.8% | 3.5% | — |
| Net income | -$18.7M | $2.8M | $3.0M | $10.7M | — |
| Gross margin | 11.5% | 13.6% | 13.7% | 11.6% | — |
| Gross profit | $235M | $249M | $221M | $166M | — |
| Operating income | $83.4M | $111M | $93.0M | $49.8M | — |
Headlines — positive tone
• [OK · fundamentals] RadNet (RDNT) Posts Record Revenue But Profit Growth Lags
News
2026-10-08 · Q2 Testing & Diagnostics Services Earnings: RadNet (NASDAQ:RDNT) Earns Top Marks
2026-10-08 · New Study Shows DeepHealth AI Could Help Avoid Nearly One in Five Prostate Biopsies
2026-10-01 · Sector Update: Healthcare Stocks Decline Premarket Thursday
2026-10-01 · 3 Profitable Stocks That Fall Short
2026-10-01 · RadNet, WIN-NextGen Collaborating on Medical Imaging Career Initiative
2026-10-01 · RadNet and WIN-NextGen™ Form a Collaboration to Inspire the Next Generation of Medical Imaging Professionals
2026-09-18 · Why DataMEDS’ Acquisition Does Not Seem to Be Very Bullish for MEDS Stock at This Point
2026-09-18 · 1 High-Flying Stock Worth Your Attention and 2 We Ignore
2026-09-17 · The Pennant Group (PNTG) Moves 6.3% Higher: Will This Strength Last?
2026-09-15 · RadNet (RDNT) Stock May Be 23% Below Fair Value On Cash Flow
2026-09-09 · RadNet to Host Free Prostate Cancer Webinar on September 19, 2026
Price (daily)
Full chart · RSI · MACD · patterns